Sheng‐Wei Lin

880 citations
39 papers · 674 indexed · h-index 14
Topics
DNA Repair Mechanisms (8 papers)CRISPR and Genetic Engineering (6 papers)Biochemical and Molecular Research (4 papers)
Partner nations
TaiwanUnited StatesChina

In The Last Decade

Sheng‐Wei Lin

38 papers receiving 671 citations

Peers

Sheng‐Wei Lin
Comparison fields: 5 of 81
  • Molecular Biology 426
  • Organic Chemistry 134
  • Immunology 129
  • Oncology 76
  • Nutrition and Dietetics 71
Replace E. Papinutto with:
E. Papinutto Italy
Nehru Viji Sankaranarayanan United States
Ju Bao United States
Dirk Kuck Germany
Kym N. Lowes Australia
Dasheng Wang United States
David F. Thieker United States
Mark D. Mulcair Australia
Xueji Wu China
Soenita S. Goerdayal Netherlands
Sheng‐Wei Lin relative to E. Papinutto Italy E. Papinutto's profile →
Citations per field
00.5×5.3×
E. Papinutto · 1×
Citations per year

Countries citing papers authored by Sheng‐Wei Lin

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Wei Lin more than expected).

Fields of papers citing papers by Sheng‐Wei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Wei Lin. The network helps show where Sheng‐Wei Lin may publish in the future.

Co-authorship network of co-authors of Sheng‐Wei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Wei Lin. A scholar is included among the top collaborators of Sheng‐Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Wei Lin. Sheng‐Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 4
5 2
6 3
7 1
8 3
9 8
10 5
11 2
12 12
13 12
14 83
15 13
16 55
17 22
18 26
19 34
20 6

About Sheng‐Wei Lin

Sheng‐Wei Lin is a scholar working on Molecular Biology, Immunology and Oncology, having authored 39 papers that have together received 674 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (8 papers), CRISPR and Genetic Engineering (6 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Molecular Biology (426 citations), Immunology (129 citations) and Organic Chemistry (134 citations). Sheng‐Wei Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Po‐Huang Liang, Vathan Kumar, Yingming Wang, Andrew H.-J. Wang, Chun‐Nan Lin, Chia‐Ling Liu, Peter Chi, Tzu‐Ping Ko, Chun‐Hung Lin and Tsui-Ling Hsu. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026